FENC
Fennec Pharmaceuticals Inc
10.60$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.9% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +802.9% | +1,284.5% | +123.7% | -6.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,364.0% | +152.9% | +18.2% | |
| – | +0.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | +1,279.8% | +121.8% | -7.8% | |
| – | +0.0% | +64.1% | +13.2% | +1.2% | +246.8% | +12.6% | -22.1% | -5.0% | -79.6% | -66.5% | +111.0% | +38.9% | -71.2% | -40.2% | -28.3% | +84.4% | +310.2% | +158.7% | +12.0% | -9.0% | -2.4% | -29.1% | -98.4% | +448.2% | -18.6% | |
| – | +64.1% | +51.4% | +31.2% | +35.5% | +124.6% | +9.1% | -80.5% | +7.4% | -65.5% | +220.9% | -50.1% | -20.5% | -13.7% | +88.9% | -35.2% | +46.8% | +109.0% | +7.7% | +37.0% | +75.0% | -5.5% | +44.8% | +16.2% | +12.0% | +22.7% | |
| – | +0.0% | +49.4% | +66.9% | +39.7% | +94.7% | +3.9% | -25.6% | -2.1% | -79.6% | +62.7% | -25.3% | +5.3% | -46.7% | +49.0% | -34.3% | +51.9% | +142.1% | +49.7% | +25.0% | +38.8% | -4.6% | +40.4% | +36.6% | +26.7% | +12.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -356.0% | |
| – | – | – | – | – | -97.5% | -72.7% | -100.0% | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | +1,300.0% | +676.2% | +247.0% | +19.9% | -48.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -210.2% | – | -217.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +53.7% | +51.5% | -113.9% | – | – | – | – | +1.8% | -77.9% | +159.7% | -100.5% | – | -108.0% | – | – | – | – | – | – | – | – | +922.7% | -100.0% | +36,499,900.0% | -71.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -210.2% | – | -217.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -213.9% | – | -216.0% | – | – | -215.9% | – | -2,584.6% | – | – | – | – | – | -255.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.